TO KNOW ABOUT HOW THE IMMUNOHISTOCHEMICAL MARKERS PD-1 AND PD-L1 WILL EXPRESS IN BREAST CARCINOMA AND TO CORRELATE WITH IMMUNOTHERAPEUTIC INTERVENTIO
Not Applicable
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2023/07/055103
- Lead Sponsor
- Jawaharlal Nehru Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All cases having a histopathological diagnosis of breast carcinoma and all modified radical mastectomy specimens.
Exclusion Criteria
Cases of adenomas, malignant lymphomas, myoepithelial lesions, nipple tumors, fibroepithelial tumors, and mesenchymal tumors, in male patients having breast carcinoma.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method